Paracoccidioides brasiliensis
Paracoccidioides brasiliensis is a thermally dimorphic fungus that is the causative agent of Paracoccidioidomycosis, a major endemic mycosis in Latin America. It is a member of the family Ajellomycetaceae and is found in soil and vegetation.
Life Cycle[edit]
The life cycle of Paracoccidioides brasiliensis involves a transition between a mycelial form at environmental temperatures (22-28°C) and a yeast form at body temperature (35-37°C) in mammalian hosts. This transition is critical for the pathogenicity of this fungus.
Pathogenesis and Clinical Manifestations[edit]
Infection with Paracoccidioides brasiliensis usually occurs through inhalation of airborne conidia. The conidia transform into yeast cells in the lungs and can disseminate to other parts of the body, causing systemic disease. Clinical manifestations of paracoccidioidomycosis can range from asymptomatic infection to severe, life-threatening disease. Symptoms can include chronic cough, weight loss, and skin lesions.
Diagnosis and Treatment[edit]
Diagnosis of paracoccidioidomycosis is typically made by identification of the characteristic multiple budding yeast cells in clinical specimens or by serologic testing. Treatment usually involves long-term therapy with antifungal drugs, such as itraconazole or sulfamethoxazole-trimethoprim.
Epidemiology[edit]
Paracoccidioides brasiliensis is endemic to Latin America, with the highest prevalence in Brazil, Argentina, Venezuela, and Colombia. The disease is most common in rural areas among individuals involved in agricultural activities, particularly coffee cultivation.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
